Metabolism of dacarbazine by rat liver microsomes contribution of CYP1A enzymes to dacarbazine N-demethylation

Drug Metabolism and Disposition

Volumn 26, Issue 4, 1998, Pages 379-382

  Yamagata, Shin Ichi ^b   Ohmori, Shigeru ^b   Suzuki, Naoko ^b   Yoshino, Masaki ^b   Hino, Mayuko ^b   Ishii, Itsuko ^b   Kitada, Mitsukazu ^a  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA NAPHTHOFLAVONE; DACARBAZINE; ETHOXYRESORUFIN DEETHYLASE;

ANIMAL EXPERIMENT; ARTICLE; DEMETHYLATION; DRUG METABOLISM; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER MICROSOME METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031918603     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Newell D, Gescher A, Harland S, Ross D and Rutty C (1987) N-Methyl antitumor agents. A distinct class of anticancer drug? Cancer Chemother Pharmacol 19:91-102.
2. Lee SM, Thachere N, Crowther D and Margison GP (1992) In vitro depletion of O6-alkylguanine-DNA alkylatransferase in lymphocytes and melanoma of patients treated with CB10-277, a new DTIC analogue. Cancer Chemother Pharmacol 31:240-246.
3. Mitchell RB and Dolan ME (1993) Effect of temozolomide and dacarbazine on O6-alkylguanine-DNA alkylatransferase activity and sensitivity of human tumor cells and xenogragts to 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Chemother Pharmacol 32:59-63.
4. Beal DD, Skibba JL, Croft WA, Cohen SM and Brayn GT (1975) Carcinogenicity of the antineoplastic agent, 5-(3,3-dimethyl-1-triazene)-imidazole 4-carboxamide and its metabolites in rats. J Natl Cancer Inst 54:951-957.
5. Audette RCS, Connors TA, Mandel HG, Merai K and Ross WCJ (1973) Studies on the metabolism of action of the tumor inhibitory triazenes. Biochem Pharmacol 22:1855-1864.
6. Gescher A, Hickman JA, Simmonds RJ, Stevens MFG and Vaughan R (1981) Studies of the mode of action of antitumor triazenes and triazines. II. Investigation of the selective toxicity of 1-aryl-3,3-dimethyltriazenes. Biochem Pharmacol 30:89-93.
7. Breithaupt H, Dammann A, and Aigner K (1982) Pharmacokinetics of dacarbazine (DTIC) and its metabolites 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules. Cancer Chemother Pharmacol 9:103-109.
8. Skibba JL and Bryan GT (1970) N-demethylation of the antineoplastic agent 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5-(4)-carboxamide by rat and man. Cancer Res 30:147-150.
9. Hill DL (1975) Microsomal metabolism of triazenoimidazoles. Cancer Res 35:3106-3110.
10. Kolar GF, Maurer M and Wildschutte M (1980) 5-(3-Hydroxymethyl-3-methyltriazeno)imidazole-4-carboxamide is a metabolite of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DIC, DTIC, NSC45388). Cancer Lett 10:235-241.
11. Nagasawa HT, Shirota FN and Mizuno NS (1974) The mechanism of alkylation of DNA by 5-(3-methyll-1triazeno)-imidazole-4carboxamide (MIC), a metabolite of DIC (NSC45388). Non involvement of diazomethane. Chem Biol Interact 8:403-413.
12. Mizuno NS and Decker RW (1976) Alteration of DNA by 5-(3-methyl-1-triazeno)-imidazole-4-carboxamide (NSC407347). Biochem Pharmacol 25:2643-2647.
13. Spassova MK and Golvovinsky EV (1985) Pharmacobiochemistry of aryl alkyltriazenes and their application in cancer chemotherapy. Pharmacol Ther 27:333-352.
14. Mudipalli A, Nadadur SS, Maccubbin AE and Gurtoo HL (1995) Mutations induced by dacarbazine activated with cytochrome P-450. Mutation Res 327:113-120.
15. Kamataki T, Maeda K, Yamazoe Y, Matsuda K, Ishii K and Kato R (1983) A high-spin form of cytochrome P450 highly purified from polychlorinated biphenyl-treated rats catalytic characterization and immunochemichal quantitation in liver microsomes. Mol Pharmacol 24:146-155.
16. Kitada K, Sakamoto M, Rikihisa T and Kanakubo Y (1984) The interaction between two forms of cytochrome P450 during drug oxiation in the reconstituted system containing limited amount of NADPH-cytochrome P450 reductase. Biochem Pharmacol 33:3971-3976.
17. Shimada T, Misono KS and Guengerich FP (1986) Human liver microsomal cytochrome P450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. J Biol Chem 261:909-921.
18. Komori M, Hashizume T, Ohi H, Miura T, Kitada M, Nagashima K and Kamataki T (1988) Cytochrome P450 in human liver microsomes: high-performance liquid chromatographic isolation of three forms and their characterization. J Biochem 104:912-916.
19. Kamataki T, Belcher DH and Neal RA (1976) Studies on the metabolism of diethyl p-nitrophenyl phosphothionate (parathion) and benzphetamine using an apparently homogenous preparation of rat liver cytochrome P450: effect of a cytochrome P450 antibodies preparation. Mol Pharmacol 12:921-932.
20. Kitada M, Hasunuma Y, Rikihisa T and Kanakubo Y (1986) Enhancement of aniline hydroxylation in human liver microsomes. Res Commun Chem Pathol Pharmacol 51:101-116.
21. Loo TL, Housholder GE, Gerulath AH, Saunders PH and Farquhar D (1976) Mechanisms of action and pharmacology studies with DTIC. Cancer Treat Reports 60:149-152.
22. Buesa JM and Urrechaga E (1991) Clinical Pharmacokinetics of high-dose DTIC. Cancer Chemother Pharmacol 28:475-479.
23. Nash T (1953) The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J 55:416-421.
24. Rapoport R, Hanukoglu I and Skkan D (1994) A fluorimetric assay for hydrogen peroxide, suitable for NADP(H)-dependent superoxide generating redox systems. Anal Biochem 218: 309-313.
25. Loft S, Otton SV, Lennard MS, Tucker GT and Poulsen HE (1991) Characterization of metronidazole metabolism by human liver microsomes. Biochem Pharmacol 41:1127-1134.
26. Lowry OH, Rosebrough NJ, Fair AL and Randall RJ (1951) Protein measurement with the folin phenol reagent. J Bio Chem 193:265-279.
27. Laemmli UK (1970) Cleavage of structal proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227:680-685.
28. Guengerich FP, Wang P and Davidson NK (1982) Estimation of isozymes of microsomal cytochrome P450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochem 21:1698-1706.
29. Boobis AR, Kahn GC, Whyte C, Brodie MJ and Davies DS (1981) Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomes. Biochem Pharmacol 30:2451-2456.
30. Seardic D, Edwards RJ, Davies DS, Thomas PE, Levin W and Boodis AR (1990) High affinity phenacetin O-deethylase is catalyzed specifically by cytochrome P450 d (P450 1A2) in the liver of the rat. Biochem Pharmacol 39:489-498.
31. Shimada T, Yamazaki H, Mimura M, Inui Y and Guengerich FP (1994) Interindividual variation in human liver cytochrome P450 enzymes involved in oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
32. Pantuch EJ, Hsiao KC, Maggio A, Nakamura K, Kuntzuman R and Conney AH (1974) Effect of cigarette smoking on phenacetin metabolism. Clin Pharmacol Ther 15:9-17.